BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26509912)

  • 1. Oncogenic Activation of the Wnt/β-Catenin Signaling Pathway in Signet Ring Stromal Cell Tumor of the Ovary.
    Kopczynski J; Kowalik A; Chłopek M; Wang ZF; Góźdź S; Lasota J; Miettinen M
    Appl Immunohistochem Mol Morphol; 2016; 24(5):e28-33. PubMed ID: 26509912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral Signet-ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing.
    Chen PH; Hui P; Buza N
    Int J Gynecol Pathol; 2020 Mar; 39(2):193-198. PubMed ID: 30676431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian Signet-ring Stromal Tumor: A Morphologic, Immunohistochemical, and Molecular Study of 7 Cases With Discussion of the Differential Diagnosis.
    Tchrakian N; Oliva E; Chong AS; Rivera-Polo B; Bennett JA; Nucci MR; Sah S; Schoolmeester JK; van der Griend RA; Foulkes WD; Clarke BA; Young RH; McCluggage WG
    Am J Surg Pathol; 2022 Dec; 46(12):1599-1610. PubMed ID: 36040033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations.
    Irving JA; Lee CH; Yip S; Oliva E; McCluggage WG; Young RH
    Am J Surg Pathol; 2015 Oct; 39(10):1420-6. PubMed ID: 26200099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.
    Zhai Y; Iura A; Yeasmin S; Wiese AB; Wu R; Feng Y; Fearon ER; Cho KR
    Oncogene; 2011 Oct; 30(40):4152-62. PubMed ID: 21499300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signet ring stromal cell tumor revisited and related signet ring cell lesions of the ovary.
    Roth LM; Ramzy I
    Hum Pathol; 2014 Mar; 45(3):636-42. PubMed ID: 24342431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors.
    Maeda D; Shibahara J; Sakuma T; Isobe M; Teshima S; Mori M; Oda K; Nakagawa S; Taketani Y; Ishikawa S; Fukayama M
    Am J Surg Pathol; 2011 Oct; 35(10):1429-40. PubMed ID: 21881488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Wnt/beta-catenin signaling in distinct histologic subtypes of human germ cell tumors.
    Fritsch MK; Schneider DT; Schuster AE; Murdoch FE; Perlman EJ
    Pediatr Dev Pathol; 2006; 9(2):115-31. PubMed ID: 16822086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.
    Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K
    Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerosing stromal tumor of the ovary in a 4-year-old girl with characteristics of an ovarian signet-ring stromal tumor.
    He Y; Yang KX; Jiang W; Wang DQ; Li L
    Pathol Res Pract; 2010 May; 206(5):338-41. PubMed ID: 19604650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Suppressor Lzap Suppresses Wnt/β-Catenin Signaling to Promote Zebrafish Embryonic Ventral Cell Fates via the Suppression of Inhibitory Phosphorylation of Glycogen Synthase Kinase 3.
    Lin KY; Kao SH; Lai CM; Chen CT; Wu CY; Hsu HJ; Wang WD
    J Biol Chem; 2015 Dec; 290(50):29808-19. PubMed ID: 26475862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
    Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
    World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
    Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
    Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN.
    Tanwar PS; Zhang L; Kaneko-Tarui T; Curley MD; Taketo MM; Rani P; Roberts DJ; Teixeira JM
    PLoS One; 2011; 6(6):e20715. PubMed ID: 21695255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent RNF43 mutation contributes to moderate activation of Wnt signaling in colorectal signet-ring cell carcinoma.
    Li Y; Li J; Wang R; Zhang L; Fu G; Wang X; Wang Y; Fang C; Zhang D; Du D; Ma X; Pan M; Guo Q; Xu X; Hu X; Zhou Y; Mo S; Wang H; Gao J; Huang S; Liu Y; Cai S; Hua G; Peng J; Yu FX
    Protein Cell; 2020 Apr; 11(4):292-298. PubMed ID: 32008206
    [No Abstract]   [Full Text] [Related]  

  • 17. β-catenin mutation in ovarian solid pseudopapillary neoplasm.
    Kominami A; Fujino M; Murakami H; Ito M
    Pathol Int; 2014 Sep; 64(9):460-4. PubMed ID: 25186079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression.
    Prasad CP; Gupta SD; Rath G; Ralhan R
    Oncology; 2007; 73(1-2):112-7. PubMed ID: 18337623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of long non-coding RNA antisense non-coding RNA in the INK4 locus suppresses OVCAR-3 cells proliferation and induction of apoptosis by Wnt/β-catenin.
    Sun L; Cui Y; Jiang K; Li J
    J Pharm Pharmacol; 2021 Aug; 73(9):1212-1217. PubMed ID: 33772549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microcystic stromal tumour of the ovary: frequent mutations of β-catenin (CTNNB1) in six cases.
    Bi R; Bai QM; Yang F; Wu LJ; Cheng YF; Shen XX; Cai X; Zhou XY; Yang WT
    Histopathology; 2015 Dec; 67(6):872-9. PubMed ID: 25913412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.